227 related articles for article (PubMed ID: 35912842)
1. Management of progressive pulmonary fibrosis associated with connective tissue disease.
Molina-Molina M; Castellví I; Valenzuela C; Ramirez J; Rodríguez Portal JA; Franquet T; Narváez J
Expert Rev Respir Med; 2022 Jul; 16(7):765-774. PubMed ID: 35912842
[TBL] [Abstract][Full Text] [Related]
2. Clinical effect of progressive pulmonary fibrosis on patients with connective tissue disease-associated interstitial lung disease: a single center retrospective cohort study.
Lee JK; Ahn Y; Noh HN; Lee SM; Yoo B; Lee CK; Kim YG; Hong S; Ahn SM; Kim HC
Clin Exp Med; 2023 Dec; 23(8):4797-4807. PubMed ID: 37831431
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the diagnostic criteria for progressive pulmonary fibrosis in connective tissue disease related interstitial lung disease.
Lee J; Kim K; Jo YS
Respir Med; 2023 Jun; 212():107242. PubMed ID: 37031806
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide for connective tissue disease-associated interstitial lung disease.
Barnes H; Holland AE; Westall GP; Goh NS; Glaspole IN
Cochrane Database Syst Rev; 2018 Jan; 1(1):CD010908. PubMed ID: 29297205
[TBL] [Abstract][Full Text] [Related]
5. Factors for progressive pulmonary fibrosis in connective tissue disease-related interstitial lung disease.
Kim K; Lee J; Jo YS
Ther Adv Respir Dis; 2023; 17():17534666231212301. PubMed ID: 37991015
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of interstitial lung disease (ILD) secondary to systemic sclerosis (SSc) and rheumatoid arthritis (RA) and identification of 'progressive pulmonary fibrosis' using chest CT: a narrative review.
Poerio A; Carlicchi E; Zompatori M
Clin Exp Med; 2023 Dec; 23(8):4721-4728. PubMed ID: 37803100
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).
Spagnolo P; Distler O; Ryerson CJ; Tzouvelekis A; Lee JS; Bonella F; Bouros D; Hoffmann-Vold AM; Crestani B; Matteson EL
Ann Rheum Dis; 2021 Feb; 80(2):143-150. PubMed ID: 33037004
[TBL] [Abstract][Full Text] [Related]
8. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
9. Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis.
Koo BS; Park KY; Lee HJ; Kim HJ; Ahn HS; Yim SY; Jun JB
Arthritis Res Ther; 2021 Apr; 23(1):100. PubMed ID: 33823923
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.
Vij R; Strek ME
Chest; 2013 Mar; 143(3):814-824. PubMed ID: 23460159
[TBL] [Abstract][Full Text] [Related]
11. Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study.
Sambataro G; Libra A; Spicuzza L; Palmucci S; Conti P; Spagnolo E; Colaci M; Malatino L; Orlandi M; Sambataro D; Vancheri C
Respiration; 2023; 102(6):405-415. PubMed ID: 37231870
[TBL] [Abstract][Full Text] [Related]
12. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of lung fibrosis in systemic rheumatic diseases (new treatment)].
Buschulte K; Hoffmann-Vold AM; Dobrota RD; Höger P; Krause A; Kreuter M
Z Rheumatol; 2021 Oct; 80(8):743-754. PubMed ID: 34505934
[TBL] [Abstract][Full Text] [Related]
14. The potential utility of anterior upper lobe honeycomb-like lesion in interstitial lung disease associated with connective tissue disease.
Yamakawa H; Ogura T; Sato S; Nishizawa T; Kawabe R; Oba T; Kato A; Horikoshi M; Akasaka K; Amano M; Kuwano K; Sasaki H; Baba T; Matsushima H
Respir Med; 2020 Oct; 172():106125. PubMed ID: 32911135
[TBL] [Abstract][Full Text] [Related]
15. Connective Tissue Disease-Associated Interstitial Lung Disease: A Focused Review.
Solomon JJ; Fischer A
J Intensive Care Med; 2015 Oct; 30(7):392-400. PubMed ID: 24371251
[TBL] [Abstract][Full Text] [Related]
16. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue disease-associated interstitial lung disease.
Storrer KM; Müller CS; Pessoa MCA; Pereira CAC
J Bras Pneumol; 2024; 50(1):e20230132. PubMed ID: 38536980
[TBL] [Abstract][Full Text] [Related]
18. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
19. Management of interstitial lung disease associated with connective tissue disease.
Mathai SC; Danoff SK
BMJ; 2016 Feb; 352():h6819. PubMed ID: 26912511
[TBL] [Abstract][Full Text] [Related]
20. Predictors for progressive fibrosis in patients with connective tissue disease associated interstitial lung diseases.
Chiu YH; Spierings J; de Jong PA; Hoesein FM; Grutters JC; van Laar JM; Voortman M
Respir Med; 2021 Oct; 187():106579. PubMed ID: 34438351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]